期刊文献+

ITP-BAT出血评分系统在原发免疫性血小板减少症的临床应用价值 被引量:9

Clinical significance of ITP-BAT bleeding grading system for patients with immune thrombocytopenia
原文传递
导出
摘要 目的 研究ITP-BAT出血评分系统在原发免疫性血小板减少症(ITP)的临床应用价值.方法 采用ITP-BAT出血评分系统对183例ITP患者进行出血评分及出血严重程度分级,分析ITP患者出血评分与血小板计数、年龄、性别、疾病分期的关系以及ITP-BAT出血评分系统的反应度、重测可信度.结果 ITP患者出血程度与血小板计数呈负相关(r=-0.744,P<0.01),PLT≤20×109/L时,患者出血程度加重(χ^2=82.40,P<0.01).儿童患者轻度出血占68.4%(26/38),与其他年龄组比较差异有统计学意义(χ^2=8.839,P<0.01).年龄≥60岁老年患者严重出血占老年患者14.3%(3/21),与其他年龄组比较差异有统计学意义(χ^2=7.056,P<0.01).性别和疾病分期在出血程度上差异无统计学意义(χ^2=4.922,P>0.05;χ^2=3.411,P>0.05).ITP患者治疗前后出血评分差异具有统计学意义(Z=-6.61,P<0.01).两名医师评分结果完全相同的比例为66.1%(κ=0.561),同一名医师两次评分结果完全相同的比例为94.7%(κ=0.874).结论 ITP-BAT出血评分系统在中国ITP患者中有很好的效度和反应度,与临床指标密切相关,能敏感地反映患者出血症状的变化,可以作为治疗的参考指标和疗效的观察指标. Objective To explore the clinical significance,reliability and responsiveness of ITP-BAT bleeding grading system for patients with immune thrombocytopenia(ITP).Methods One hundred and eighty-three patients with ITP were assessed by using of ITP-BAT bleeding grading system.Test-retest reliability,responsiveness of ITP-BAT bleeding grading system and association between bleeding grades and platelet counts,age,gender,disease stage were analyzed.Results Bleeding degree of ITP patients and the platelet count were negatively correlated (r=-0.744,P〈0.01) and bleeding degree increased significantly with platelet counts below 20 × 109/L (χ^2=82.40,P〈0.01).Mild bleeding rate in children was 68.5%,higher than that in adult (χ^2=8.839,P〈0.01),and severe bleeding rate in the elderly was 14.3%,higher than that in non-elderly (χ^2=7.056,P〈0.01).There were no significant differences in bleeding degree in patients with different gender and disease stage (χ^2=4.922,P〉0.05 and χ^2=3.411,P〉0.05).Bleeding grades before and after treatment had more significant difference (Z=-6.61,P〈0.01).Scoring consistency of two doctors was 66.1% (κ=0.561),and scoring consistency of the same doctor was 94.7% (κ=0.874).Conclusions ITP-BAT bleeding grading system in China has good validity and responsiveness,closely related to clinical indicators.It is sensitive to the variation of the hemorrhage in patients.ITP-BAT could be used as a reference index of the treatment,and also be used as an observation index of curative effect.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第9期812-815,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(81070397、81270581) 科技部重大血液病新药临床评价研究技术平台体系建设(2011ZX 09302-007-04) 卫生公益性行业科研专项(201202017)
关键词 血小板减少 出血评分 血小板计数 Thrombocytopenia Bleeding grading Platelet count
  • 相关文献

参考文献10

  • 1Buchanan GR,Adix L.Grading of hemorrhage in children with idiopathic thrombocytopenic purpura[J].J Pediatr,2002,141(5):683-688.
  • 2Page LK,Psaila B,Provan D,et al.The immune thrombocytopenic purpura (ITP) bleeding score:assessment of bleeding in patients with ITP[J].Br J Hematol,2007,138(2):245-248.
  • 3王晓燕,李晶晶,陈振萍,葛菁,季林祥,杨仁池.出血分级在特发性血小板减少性紫癜患者中的临床意义[J].山东医药,2008,48(10):11-13. 被引量:6
  • 4Rodeghiero F,Michel M,Gernsheimer T,et al.Standardization of bleeding assessment in immune thrombocytopenia:report from the International Working Group[J].Blood,2013,121(14):2596-2606.
  • 5无,侯明.成人原发免疫性血小板减少症诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):975-977. 被引量:191
  • 6Neunert C,Lim W,Crowther M,et al.The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J].Blood,2011,117(16):4190-4207.
  • 7Fogarty PF,Tarantino MD,Brainsky A,et al.Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia[J].Curr Med Res Opin,2012,28 (1):79-87.
  • 8Zhou H,Fu R,Wang H,et al.Immune thrombocytopenia in the elderly:clinical course in 525 patients from a single center in China[J].Ann Hematol,2013,92(1):79-87.
  • 9Neunert CE,Buchanan GR,Imbach P,et al.Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura[J].Blood,2008,112(10):4003-4008.
  • 10Fogarty PF,Segal JB.The epidemiology of immune thrombocytopenic purpura[J].Curr Opin Hematol,2007,14(5):515-519.

二级参考文献5

  • 1Page LK, Psaila B, Provan D, et al. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP[J]. Br J Hematol,2007,138(2) :245-248.
  • 2Buchanan GR, Adix L. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura[ J ]. Semin Thromb Hemost, 2001,27 (3) :277-285.
  • 3Jayabose A, Semasundaram M D, Levendoglu T,et a l. Long-term outcome of chronic idiopathic thrombocytopenic purpura in children [ J ]. J Pediatr Hematol On col ,2004,26 ( 11 ) :724-726.
  • 4Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama [ J ]. Clin Pediatr (Phila) ,2004,43(8) :691-702.
  • 5Khellaf M, Michel M, Schaeffer A, et al. Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count [ J ]. Haematologica, 2005,90(6) :829-832.

共引文献195

同被引文献55

  • 1Estcourt L J, Stanworth S J, Harrison P, et al. Prospective observa- tional cohort study of the association between thromboelastome- try, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study [J]. Br J Haematol, 2014,166(4):581-591.
  • 2Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group [J].Blood, 2013,121 ( 14 ) : 2596-2606.
  • 3Rodeghiero F, Stasi R, Gemsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group [J]. Blood, 2009,113 ( 11 ) :2386- 2393.
  • 4Bolton-Maggs R Severe bleeding in idiopathic thrombocytope- nic purpura [J]. J Pediatr Hematol Oncol,2003,25 Suppl 1:$47- 51.
  • 5Psaila B, Bussel JB, Frelinger AL, et al. Differences in plateletfunction in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia [J]. J Thromb Haemost, 2011, 9( 11 ):2302-2310.
  • 6Fager AM, Wood JP, Bouehard BA, et al. Properties of procoag- ulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase [J]. Arterioscler Thromb Vasc Biol, 2010,30 (12) :2400-2407.
  • 7Adly AA, Ragab IA, Ismail EA, et al. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia [J]. Platelets, 2014,1-6. DOI: 10.3109/09537104.2014.969220.
  • 8Greene LA, Chert S, Seery C, et al. Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thromboeytopenia [ J ]. Br J Haematol, 2014,166 (4) :592-600.
  • 9Rodeghiero F, Michel M, Gernsheimer T, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group [J]. Blood, 2013, 121 (14) :2596-2606.
  • 10Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura [J]. J Pediatr, 2002, 141 (5):683-688.

引证文献9

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部